Transcat (NASDAQ:TRNS – Get Free Report)‘s stock had its “outperform” rating reiterated by Oppenheimer in a note issued to investors on Wednesday, Benzinga reports. They currently have a $130.00 price objective on the scientific and technical instruments company’s stock, down from their prior price objective of $155.00. Oppenheimer’s target price indicates a potential upside of 30.71% from the company’s current price.
Other analysts have also recently issued reports about the stock. HC Wainwright reaffirmed a “buy” rating and set a $156.00 price target on shares of Transcat in a research report on Tuesday. StockNews.com lowered shares of Transcat from a “hold” rating to a “sell” rating in a report on Tuesday. Finally, Craig Hallum decreased their price objective on shares of Transcat from $138.00 to $113.00 and set a “buy” rating for the company in a report on Wednesday. One research analyst has rated the stock with a sell rating, two have issued a hold rating and three have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and an average price target of $133.00.
Get Our Latest Report on Transcat
Transcat Stock Performance
Transcat (NASDAQ:TRNS – Get Free Report) last posted its quarterly earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 EPS for the quarter, missing the consensus estimate of $0.47 by ($0.12). The business had revenue of $67.83 million during the quarter, compared to analysts’ expectations of $70.30 million. Transcat had a net margin of 5.69% and a return on equity of 8.48%. The company’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.41 EPS. On average, analysts forecast that Transcat will post 2.06 EPS for the current fiscal year.
Institutional Investors Weigh In On Transcat
A number of hedge funds have recently made changes to their positions in TRNS. Conestoga Capital Advisors LLC lifted its position in Transcat by 17.9% in the third quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock worth $109,561,000 after purchasing an additional 137,830 shares during the period. Hood River Capital Management LLC boosted its position in shares of Transcat by 21.6% during the 2nd quarter. Hood River Capital Management LLC now owns 196,838 shares of the scientific and technical instruments company’s stock valued at $23,558,000 after purchasing an additional 34,947 shares in the last quarter. Wealth Enhancement Advisory Services LLC grew its stake in shares of Transcat by 28.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 79,303 shares of the scientific and technical instruments company’s stock worth $9,577,000 after purchasing an additional 17,743 shares during the last quarter. Raymond James & Associates raised its holdings in shares of Transcat by 157.2% in the 3rd quarter. Raymond James & Associates now owns 20,651 shares of the scientific and technical instruments company’s stock worth $2,494,000 after purchasing an additional 12,622 shares in the last quarter. Finally, Janus Henderson Group PLC lifted its stake in Transcat by 208.3% during the first quarter. Janus Henderson Group PLC now owns 10,297 shares of the scientific and technical instruments company’s stock valued at $1,147,000 after purchasing an additional 6,957 shares during the last quarter. Institutional investors own 98.34% of the company’s stock.
About Transcat
Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.
Featured Stories
- Five stocks we like better than Transcat
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- How to Use the MarketBeat Dividend Calculator
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- Using the MarketBeat Dividend Yield Calculator
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.